What We Do

As a pioneering biotech company, ImmuNova BioMed specializes in developing groundbreaking peptide-based immunotherapeutics. Our innovative nanoparticle delivery systems enable precise, targeted, and controlled activation of immune cells to effectively recognize and eliminate cancer cells.